The future burden of obesity in Canada: a modelling study.


Journal

Canadian journal of public health = Revue canadienne de sante publique
ISSN: 1920-7476
Titre abrégé: Can J Public Health
Pays: Switzerland
ID NLM: 0372714

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 03 2019
accepted: 16 07 2019
pubmed: 21 8 2019
medline: 10 4 2020
entrez: 21 8 2019
Statut: ppublish

Résumé

We applied the validated Obesity Population Risk Tool (OPoRT) to estimate the future burden of obesity in Canada using baseline risk factors attained through routinely collected survey data. OPoRT was developed using logistic regression with sex-specific generalized estimating equations to predict the 10-year prevalence of obesity (outcome BMI ≥ 30.0) among adults 18 and older. The algorithm includes 17 predictive factors, including socio-demographic and health behavioural characteristics. OPoRT demonstrated excellent discrimination (C-statistic ≥ 0.89) and achieved calibration. We applied OPoRT to Canadian Community Health Survey (2013/14) data to predict the future prevalence of obesity in Canada for a variety of population subgroups. The predicted burden of obesity grew from 261 cases per 1000 in 2013/14 to 326 cases per 1000 in 2023/24 corresponding to a total of 8.54 million individuals with obesity. The burden is expected to be higher among males (347 cases per 1000) than females (305 cases per 1000). Individuals aged 35-49 had the highest predicted burden of obesity (374 cases per 1000) and the largest number of predicted cases (2.42 million), while individuals in the ≥ 65 age group had the lowest predicted burden (236 cases per 1000). The number of individuals with obesity per 1000 is highest among those severely food insecure (452 cases per 1000), compared with food secure individuals (324 cases per 1000). OPoRT can be used to estimate the future population burden of obesity, to identify priority subgroups at an elevated risk. Burden estimates should be reflected in approaches to curb the future burden of obesity.

Identifiants

pubmed: 31429040
doi: 10.17269/s41997-019-00251-y
pii: 10.17269/s41997-019-00251-y
pmc: PMC6900264
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

768-778

Subventions

Organisme : CIHR
ID : MOP137130
Pays : Canada

Références

J Clin Endocrinol Metab. 2008 Dec;93(12):4576-99
pubmed: 18782869
Int J Cardiol. 2013 Jun 5;166(1):111-7
pubmed: 22088224
Ann Hum Biol. 2018 Sep - Dec;45(6-8):478-485
pubmed: 30497298
BMC Med. 2013 Feb 18;11:41
pubmed: 23414295
CMAJ. 2018 Aug 13;190(32):E947-E948
pubmed: 30104187
Pediatrics. 2000 Jul;106(1):E14
pubmed: 10878183
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
Int J Equity Health. 2010 Nov 24;9:27
pubmed: 21106100
PLoS One. 2013 Jul 16;8(7):e67429
pubmed: 23874419
Am J Prev Med. 1997 Jul-Aug;13(4):317-23
pubmed: 9236971
Health Rep. 2011 Sep;22(3):35-45
pubmed: 22106788
CMAJ Open. 2014 May 20;2(2):E94-E101
pubmed: 25077135
Eur Radiol. 2015 Oct;25(10):3093-9
pubmed: 25764091
JAMA. 2018 Feb 13;319(6):540
pubmed: 29450533
Lancet. 2015 Jun 13;385(9985):2400-9
pubmed: 25703111
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
Obesity (Silver Spring). 2009 May;17(5):941-64
pubmed: 19165161
BMJ Open. 2014 Jul 25;4(7):e004787
pubmed: 25063459
Can J Diabetes. 2013 Apr;37(2):90-6
pubmed: 24070798
Obes Rev. 2012 Nov;13(11):1067-79
pubmed: 22764734
Lancet. 2012 Jul 21;380(9838):247-57
pubmed: 22818937
PLoS One. 2018 Jan 18;13(1):e0191169
pubmed: 29346391
N Engl J Med. 2011 Nov 17;365(20):1876-85
pubmed: 22087679
Lancet. 2010 Nov 20;376(9754):1775-84
pubmed: 21074255
Health Place. 2017 Nov;48:1-10
pubmed: 28888131
J Epidemiol Community Health. 2011 Jul;65(7):613-20
pubmed: 20515896
J Epidemiol Community Health. 2012 Oct;66(10):859-65
pubmed: 22859516
Br J Cancer. 2018 Mar 6;118(5):750-759
pubmed: 29381683

Auteurs

Meghan O'Neill (M)

Dalla Lana School of Public Health, University of Toronto, 155 College Street, Health Sciences Building 6th Floor, Suite 600, Toronto, ON, M5T 3M7, Canada.

Kathy Kornas (K)

Dalla Lana School of Public Health, University of Toronto, 155 College Street, Health Sciences Building 6th Floor, Suite 600, Toronto, ON, M5T 3M7, Canada.

Laura Rosella (L)

Dalla Lana School of Public Health, University of Toronto, 155 College Street, Health Sciences Building 6th Floor, Suite 600, Toronto, ON, M5T 3M7, Canada. laura.rosella@utoronto.ca.
Institute for Clinical Evaluative Sciences, Room 424, 155 College Street, Toronto, ON, Canada. laura.rosella@utoronto.ca.
Public Health Ontario, 480 University Avenue, Suite 300, Toronto, ON, M5G 1V2, Canada. laura.rosella@utoronto.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH